Patents by Inventor Stuart J. Updike

Stuart J. Updike has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Low oxygen in vivo analyte sensor
    Patent number: 11596332
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: March 7, 2023
    Assignee: Dexcom, Inc.
    Inventors: Mark C. Shults, Rathbun K. Rhodes, Stuart J. Updike, James H. Brauker
  • Low oxygen in vivo analyte sensor
    Patent number: 11191458
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: December 7, 2021
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Rathbun K. Rhodes, Stuart J. Updike, James H. Brauker
  • LOW OXYGEN IN VIVO ANALYTE SENSOR
    Publication number: 20210353187
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Application
    Filed: July 30, 2021
    Publication date: November 18, 2021
    Inventors: Mark C. Shults, Rathbun K. Rhodes, Stuart J. Updike, James H. Brauker
  • DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS
    Publication number: 20190239782
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: April 18, 2019
    Publication date: August 8, 2019
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
  • LOW OXYGEN IN VIVO ANALYTE SENSOR
    Publication number: 20190183396
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Application
    Filed: February 25, 2019
    Publication date: June 20, 2019
    Inventors: Mark C. Shults, Rathbun K. Rhodes, Stuart J. Updike, James H. Brauker
  • Low oxygen in vivo analyte sensor
    Patent number: 10265000
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: April 23, 2019
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Rathbun K. Rhodes, Stuart J. Updike, James H. Brauker
  • DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS
    Publication number: 20180192926
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: March 6, 2018
    Publication date: July 12, 2018
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
  • Device and method for determining analyte levels
    Patent number: 9931067
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: September 13, 2016
    Date of Patent: April 3, 2018
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
  • LOW OXYGEN IN VIVO ANALYTE SENSOR
    Publication number: 20170325726
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Application
    Filed: August 3, 2017
    Publication date: November 16, 2017
    Inventors: Mark C. Shults, Rathbun K. Rhodes, Stuart J. Updike, James H. Brauker
  • Low oxygen in vivo analyte sensor
    Patent number: 9757061
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: September 1, 2015
    Date of Patent: September 12, 2017
    Assignee: DexCom, Inc.
    Inventors: Mark Shults, Rathbun K. Rhodes, Stuart J. Updike, James H. Brauker
  • DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS
    Publication number: 20170020418
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: September 13, 2016
    Publication date: January 26, 2017
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
  • Device and method for determining analyte levels
    Patent number: 9439589
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: September 13, 2016
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
  • Device and method for determining analyte levels
    Patent number: 9339223
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: December 30, 2013
    Date of Patent: May 17, 2016
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
  • LOW OXYGEN IN VIVO ANALYTE SENSOR
    Publication number: 20150374270
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Application
    Filed: September 1, 2015
    Publication date: December 31, 2015
    Inventors: Mark C. Shults, Rathbun K. Rhodes, Stuart J. Updike, James H. Brauker
  • Low oxygen in vivo analyte sensor
    Patent number: 9155496
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: February 18, 2011
    Date of Patent: October 13, 2015
    Assignee: DexCom, Inc.
    Inventors: Mark Shults, Rathburn K. Rhodes, Stuart J. Updike, James H. Brauker
  • DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS
    Publication number: 20150087943
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: November 25, 2014
    Publication date: March 26, 2015
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
  • Device and method for determining analyte levels
    Patent number: 8923947
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: July 23, 2013
    Date of Patent: December 30, 2014
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
  • DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS
    Publication number: 20140128701
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: December 30, 2013
    Publication date: May 8, 2014
    Applicant: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
  • DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS
    Publication number: 20140128700
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: December 30, 2013
    Publication date: May 8, 2014
    Applicant: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
  • Device and method for determining analyte levels
    Patent number: 8676288
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: June 22, 2011
    Date of Patent: March 18, 2014
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes